Covered recipient · General Payments record
IHSAN O SAFI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,717.88
- Reported across 356 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $418.91 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $234.21 | 16 |
| Lilly USA, LLC | $118.50 | 7 |
| Xeris Pharmaceuticals, Inc. | $19.55 | 1 |
| Insulet Corporation | $16.10 | 1 |
| Amgen Inc. | $15.81 | 1 |
| Abbott Laboratories | $14.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.74 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125112818 | CMS |
| Amgen Inc. | $15.81 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111695358 | CMS |
| Insulet Corporation | $16.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116802950 | CMS |
| Lilly USA, LLC | $20.62 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135033536 | CMS |
| Lilly USA, LLC | $16.16 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985364 | CMS |
| Lilly USA, LLC | $16.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985362 | CMS |
| Lilly USA, LLC | $14.73 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135009703 | CMS |
| Lilly USA, LLC | $20.09 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135032238 | CMS |
| Lilly USA, LLC | $14.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007709 | CMS |
| Lilly USA, LLC | $15.35 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135009705 | CMS |
| Novo Nordisk Inc | $24.08 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097027075 | CMS |
| Novo Nordisk Inc | $17.29 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097710603 | CMS |
| Novo Nordisk Inc | $11.64 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097116448 | CMS |
| Novo Nordisk Inc | $14.35 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097697180 | CMS |
| Novo Nordisk Inc | $11.98 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097727425 | CMS |
| Novo Nordisk Inc | $14.31 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097333277 | CMS |
| Novo Nordisk Inc | $16.31 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097490424 | CMS |
| Novo Nordisk Inc | $21.53 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097543274 | CMS |
| Novo Nordisk Inc | $7.24 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097159029 | CMS |
| Novo Nordisk Inc | $6.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097595405 | CMS |
| Novo Nordisk Inc | $19.12 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097271786 | CMS |
| Novo Nordisk Inc | $20.11 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901193 | CMS |
| Novo Nordisk Inc | $8.59 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096639395 | CMS |
| Novo Nordisk Inc | $19.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597554 | CMS |
| Novo Nordisk Inc | $14.67 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096806266 | CMS |
| Novo Nordisk Inc | $7.44 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097196428 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.55 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144596720 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.